Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
2.

Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.

Arancio W, Pizzolanti G, Genovese SI, Pitrone M, Giordano C.

Gerontology. 2014;60(3):197-203. doi: 10.1159/000357206. Epub 2014 Feb 28. Review.

3.

Competing endogenous RNA and interactome bioinformatic analyses on human telomerase.

Arancio W, Pizzolanti G, Genovese SI, Baiamonte C, Giordano C.

Rejuvenation Res. 2014 Apr;17(2):161-7. doi: 10.1089/rej.2013.1486. Epub 2014 Apr 8.

PMID:
24713059
4.

Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.

Villa-Bellosta R, Rivera-Torres J, Osorio FG, Acín-Pérez R, Enriquez JA, López-Otín C, Andrés V.

Circulation. 2013 Jun 18;127(24):2442-51. doi: 10.1161/CIRCULATIONAHA.112.000571. Epub 2013 May 20.

5.

Hutchinson-Gilford progeria syndrome through the lens of transcription.

Prokocimer M, Barkan R, Gruenbaum Y.

Aging Cell. 2013 Aug;12(4):533-43. doi: 10.1111/acel.12070. Epub 2013 Apr 19. Review.

6.

A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.

Gonzalez JM, Pla D, Perez-Sala D, Andres V.

Front Biosci (Schol Ed). 2011 Jun 1;3:1133-46. Review.

PMID:
21622261
7.

Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.

McClintock D, Gordon LB, Djabali K.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2154-9. Epub 2006 Feb 6.

8.

Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS).

Plasilova M, Chattopadhyay C, Ghosh A, Wenzel F, Demougin P, Noppen C, Schaub N, Szinnai G, Terracciano L, Heinimann K.

PLoS One. 2011;6(6):e21433. doi: 10.1371/journal.pone.0021433. Epub 2011 Jun 27.

10.

All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.

Pellegrini C, Columbaro M, Capanni C, D'Apice MR, Cavallo C, Murdocca M, Lattanzi G, Squarzoni S.

Oncotarget. 2015 Oct 6;6(30):29914-28. doi: 10.18632/oncotarget.4939.

11.

Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.

Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik VK, Squarzoni S, Maraldi NM, Lattanzi G.

Cell Mol Life Sci. 2005 Nov;62(22):2669-78.

12.

Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging.

Rodriguez S, Coppedè F, Sagelius H, Eriksson M.

Eur J Hum Genet. 2009 Jul;17(7):928-37. doi: 10.1038/ejhg.2008.270. Epub 2009 Jan 28.

13.

Hutchinson-Gilford progeria syndrome.

Pollex RL, Hegele RA.

Clin Genet. 2004 Nov;66(5):375-81. Review.

PMID:
15479179
14.

New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.

Jung HJ, Tu Y, Yang SH, Tatar A, Nobumori C, Wu D, Young SG, Fong LG.

Hum Mol Genet. 2014 Mar 15;23(6):1506-15. doi: 10.1093/hmg/ddt537. Epub 2013 Nov 7.

15.

Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.

Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12879-84. Epub 2005 Aug 29.

16.

LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.

Kane MS, Lindsay ME, Judge DP, Barrowman J, Ap Rhys C, Simonson L, Dietz HC, Michaelis S.

Am J Med Genet A. 2013 Jul;161A(7):1599-611. doi: 10.1002/ajmg.a.35971. Epub 2013 May 10.

17.

Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.

Davies BS, Yang SH, Farber E, Lee R, Buck SB, Andres DA, Spielmann HP, Agnew BJ, Tamanoi F, Fong LG, Young SG.

J Lipid Res. 2009 Jan;50(1):126-34. doi: 10.1194/jlr.M800424-JLR200. Epub 2008 Aug 29.

18.

Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.

Luo YB, Mitrpant C, Johnsen RD, Fabian VA, Fletcher S, Mastaglia FL, Wilton SD.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2778-86. eCollection 2013.

19.

Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition.

Marji J, O'Donoghue SI, McClintock D, Satagopam VP, Schneider R, Ratner D, Worman HJ, Gordon LB, Djabali K.

PLoS One. 2010 Jun 15;5(6):e11132. doi: 10.1371/journal.pone.0011132.

20.
Items per page

Supplemental Content

Write to the Help Desk